Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis

The invention relates to pharmaceutical compositions for the treatment of multiple sclerosis which comprises a zinc-hyaluronan complex, preferably a zinc-hyaluronan complex with a molecular weight of 800-1200 kDa, as active ingredient and a pharmaceutically acceptable carrier and/or additive. The pr...

Full description

Saved in:
Bibliographic Details
Main Authors FORRAI GABORNE, SZEKELY AKOSNE, BALOGH GYOERGY T, BOROS ANDREAS, ILLES JANOS
Format Patent
LanguageEnglish
Published 31.05.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to pharmaceutical compositions for the treatment of multiple sclerosis which comprises a zinc-hyaluronan complex, preferably a zinc-hyaluronan complex with a molecular weight of 800-1200 kDa, as active ingredient and a pharmaceutically acceptable carrier and/or additive. The process for the preparation of said pharmaceutical compositions as well as the therapeutic use thereof for the treatment of multiple sclerosis are also within the scope of the invention.
Bibliography:Application Number: US20040579256